Moderna和Pfizer新冠mRNA疫苗接种后皮肤反应:基于登记研究的414例分析
最常见为迟发性大局部反应,其次为局部注射部位反应、荨麻疹样皮疹和麻疹样皮疹;大多数反应轻微且自限,未发生严重不良事件,不应因此阻碍疫苗接种。
要点
- mRNA新冠疫苗接种后皮肤反应以迟发性大局部反应最常见。
- 多数皮肤反应轻微自限,未发生严重不良事件。
核心结论
- mRNA新冠疫苗接种后皮肤反应通常轻微且自限,不应因此 discouraging 疫苗接种。
研究设计与样本
- 共记录414例皮肤反应,其中Moderna疫苗占83%,Pfizer疫苗占17%。
主要发现
- 迟发性大局部反应最常见,其次为局部注射部位反应、荨麻疹样皮疹和麻疹样皮疹。
- 较少见反应包括冻疮样皮疹、化妆品填充剂反应、带状疱疹、单纯疱疹复发和玫瑰糠疹样反应。
- 登记研究中所有患者在首剂或第二剂后均未发生严重不良事件。
临床怎么用
- 临床医生应认识到mRNA新冠疫苗接种后可出现多种皮肤反应,包括模拟SARS-CoV-2感染的冻疮样皮疹。
- 多数首剂反应患者第二剂无复发,且无严重不良事件,应鼓励完成疫苗接种。
局限性
- 登记分析无法测量发生率。
- 可能存在形态学误分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cutaneous reactions after messenger RNA (mRNA)-based COVID-19 vaccines have been reported but are not well characterized. OBJECTIVE: To evaluate the morphology and timing of cutaneous reactions after mRNA COVID-19 vaccines. METHODS: A provider-facing registry-based study collected cases of cutaneous manifestations after COVID-19 vaccination. RESULTS: From December 2020 to February 2021, we recorded 414 cutaneous reactions to mRNA COVID-19 vaccines from Moderna (83%) and Pfizer (17%). Delayed large local reactions were most common, followed by local injection site reactions, urticarial eruptions, and morbilliform eruptions. Forty-three percent of patients with first-dose reactions experienced second-dose recurrence. Additional less common reactions included pernio/chilblains, cosmetic filler reactions, zoster, herpes simplex flares, and pityriasis rosea-like reactions. LIMITATIONS: Registry analysis does not measure incidence. Morphologic misclassification is possible. CONCLUSIONS: We report a spectrum of cutaneous reactions after mRNA COVID-19 vaccines. We observed some dermatologic reactions to Moderna and Pfizer vaccines that mimicked SARS-CoV-2 infection itself, such as pernio/chilblains. Most patients with first-dose reactions did not have a second-dose reaction and serious adverse events did not develop in any of the patients in the registry after the first or second dose. Our data support that cutaneous reactions to COVID-19 vaccination are generally minor and self-limited, and should not discourage vaccination.
引用
- McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol. 2021. PMID: 33838206. doi:10.1016/j.jaad.2021.03.092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。